Topcon Screen

Diabetes Eye Exams at Point of Care

Diabetic retinopathy is the leading cause of vision loss among people with diabetes¹

Up to 50% of Americans with diabetes were not tested for diabetic retinopathy, despite the known risk of vision loss.³

More than 2 in 5 Americans with diabetes have some stage of diabetic retinopathy¹

Patients may not have any symptoms in the early stages of the disease¹

95% of vision loss can be prevented with early detection²

“This program is an effective front-line defense against diabetic retinopathy, and is a vital service to our community.”
Dr. Dina Capalongo

Medical Director of Primary Care, Crozer-Keystone Health System

Topcon Screen: Diabetic Retinopathy Screenings at Point of Care

Time, money, and transportation challenges are all barriers that might limit patients from visiting the eye doctor for diabetic retinopathy screening. Incorporating Topcon Screen as point-of-care testing for diabetic retinopathy allows you to improve patient outcomes while improving quality measures and supporting practice referrals for all eye care practitioners.

Helps detect vision abnormalities for diabetic patients early

Reimbursed by most insurance companies

Closes the Diabetes Eye Exam HEDIS/Star measure

Point-of-care testing reaches more patients

The ability to move testing closer to the patient supports the need to provide better and more convenient access to healthcare for all patients, particularly those with chronic diseases.

  • 95% of Medicare Advantage plan members with diabetes were monitored for kidney disease⁴ 
  • Only 52% of diabetes patients in the MSSP ACO program were documented to have had a diabetes eye exam⁴ 
  • By implementing Topcon Screen, primary care practices and Medicare Advantage plans can bring HEDIS compliant eye exams to the patient at point of care

1. National Eye Institute website, “Diabetic Retinopathy”, Accessed December 12, 2019.

2. American Academy of Ophthalmology website, “Sixty Percent of Americans with Diabetes Skip Annual Sight-Saving Exams”, Accessed December 12, 2019.

3. Lee DJ, Kumar N, Feuer WJ, et al. Dilated eye examination screening guideline compliance among patients with diabetes without a diabetic retinopathy diagnosis: the role of geographic access. BMJ Open Diabetes Research and Care.

4. Centers for Medicare & Medicaid Services (CMS) standard analytical file “2018 Shared Savings Program ACO Interactive dataset”, Accessed December 23, 2019, 

Questions? Ready to get started?

Let’s connect today

Whether you need product support or want to learn more about our products or services, we are standing by to help.